US Patent Issued to InCarda Therapeutics on March 17 for "Kits and methods for induction of cardioversion in subjects with atrial arrhythmias" (California Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,074, issued on March 17, was assigned to InCarda Therapeutics Inc. (West Jordan, Utah).

"Kits and methods for induction of cardioversion in subjects with atrial arrhythmias" was invented by Luiz Belardinelli (Palo Alto, Calif.), Carlos Schuler (Kensington, Calif.) and Miguel Guzman (San Jose, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods and kits for treating or preventing a heart condition, e.g., cardiac arrhythmia, e.g., atrial arrhythmia, using potassium channel inhibitors and class I antiarrhythmic agents. Also disclosed herein are methods and kits for treating a heart condition via an intravenously, orally,...